- GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic Business Wire
- Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients CNBC
- GoodRx stock soars after striking deal to sell Novo Nordisk’s GLP-1s for $499/month Yahoo Finance
- Novo Nordisk halves US price of Ozempic Financial Times
- Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers Reuters
Source link
